noninvasive glucose monitors creates convergence with the digital health era
TRANSCRIPT
Research PREVIEW for US Self-monitoring Blood Glucose (SMBG) Market
Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era
Sample of Key Highlights
The US SMBG market was valued at $3.99 billion in 2013 and is expected to increase to $4.18 billion by 2016. About 90% of the revenue is contributed by the SMBG strip market, and 10% of the demand arises from the sale of meters.
•The market is currently dominated by Roche Diagnostics (brand Accu Chek), LifeScan (J&J) (brand OneTouch), and Bayer Healthcare (CONTOUR).
•Online sales of meters and strips is increasing. Popular eCommerce vendors (e.g., Amazon) are the leaders in online supplies. Developing eCommerce channels could be an important step for any Tier II vendor fighting against mature market competitors.
•Smart phone connectivity and exploring non-invasive methods are some key areas that manufacturers are focussing on, to offer product differentiation from the competition. Thus, blood glucose meters are now increasingly becoming a part of the mhealth market.
•Within the United States, the mail order supply program has created a downside effect for small, independent retail clinics. This is also expected to make the diabetic scenario more adverse in the United States, thereby increasing the prevalence of the disease in the coming years, owing to the deficit in supply channels.
•The generic test strip market is creating stiff competition for Tier I manufacturers, forcing price pressures, thereby, shrinking the market. Currently, UniStrip Technologies has taken the forefront in the generic market. A 50-count box of its strips costs about $12. These strips will be seen flooding the shelves of retail stores for as low as $10.
Source: Frost & Sullivan analysis.
Drivers and Restraints
Denotes long-term impact
Denotes current impactSource: Frost & Sullivan analysis.
Generic test strip market will restrain growth of market leaders.
Continuous monitoring and non-invasive testing threatens the SMBG market.
Slash in Medicare reimbursement and national mail-order program to adversely affect the market.
Lack of clarity on product differentiation affects purchase decisions.
Key Takeaway: Driver 2 is the most important factor in formulating 2015 strategy.
SMBG Market: Key Market Drivers and Restraints, US, 2012-2016
Dri
vers
Res
trai
nts
Dri
vers
Res
trai
nts
Increasing prevalence of diabetes will keep the demand for SMBG meters and strips.
New product innovations surrounding connectivity and diabetes management attracts new market participants.
Executive Summary — CEO’s Perspective
2Slash in Medicare reimbursement and national mail-order program will adversely affect the market
3Continuous blood monitoring, non invasive methods and alternative markers for glycated albumin point of care testing are possible threats to the market
4 Lack of clarity on product differentiation pins down customer purchasing decisions.
1Minimal price difference between test strips and meters from different vendors creates intense competition.
Source: Frost & Sullivan analysis.
The Full Analysis Features the Following Content
Section Slide Number
Executive Summary 4
US SMBG Market Overview 8
Market Drivers and Restraints 11
US SMBG Market Forecasts (Units and Revenue Forecasts for Strips and Meters) 23
Competitor Landscape and Product Analysis 33
Key Companies to Watch 50
Strategic Recommendations 54
The Frost & Sullivan Story 58
Key Questions the Analysis Answers
Source: Frost & Sullivan analysis.
Is the market growing? How long will it continue to grow, and at what rate?
What is the current state of the competitive landscape?
What are the current industry and technology trends?
What’s the next big thing in the diabetes SMBG market landscape? Who are the new participants? What are the opportunities that a participant can capitalize on?
How is the distribution landscape currently spread out in the United States?
What are the effects of Medicare reimbursement and the national mail order program?
Interested in Full Access? Connect With Us
Kayla Belcher Corporate Communications AssociateCorporate Communications
210.247.2450
Facebookhttps://www.facebook.com/FrostandSullivan
LinkedIn Grouphttps://www.linkedin.com/company/frost-&-sullivan
SlideSharehttp://www.slideshare.net/FrostandSullivan
Twitterhttps://twitter.com/Frost_Sullivan
Frost & Sullivan Eventshttp://bit.ly/MvPRbQ
GIL Communityhttp://ww2.frost.com/gil-community/
Research Authors
Divyaa Ravishankar
Senior Industry Analyst Life sciences
Link to Peer Connect bio
Jennifer Lazar
Global Program Manager Life Sciences
Link to Peer Connect bio
Global Perspective40+ Offices Monitoring for Opportunities and Challenges
Industry ConvergenceComprehensive Industry Coverage Sparks Innovation Opportunities
Automotive&
Transportation
Aerospace & Defense Measurement &Instrumentation
Information &Communication Technologies
HealthcareEnvironment & BuildingTechnologies
Energy & PowerSystems
Chemicals, Materials& Food
Electronics &Security
Industrial Automation& Process Control
AutomotiveTransportation & Logistics
ConsumerTechnologies
Minerals & Mining